BioMerieux 2014 Revenues Increase 7 Percent, Aided by BioFire Acquisition | GenomeWeb

NEW YORK (GenomeWeb) – BioMérieux today said that its revenues for full-year 2014 rose 7 percent year over year, helped by its BioFire acquisition from a year ago. 

For the 12 months ended Dec. 31, 2014, the Marcy L'Etoile, France-based in vitro diagnostics firm reported total revenues rose to €1.70 billion ($1.90 billion) from €1.59 billion in 2013. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.